- videocam Live Webinar with Live Q&A
- calendar_month April 7, 2026 @ 1:00 PM ET/10:00 AM PT
- signal_cellular_alt Intermediate
- card_travel Patent
- schedule 90 minutes
EU Unitary Patent System and UPC: Recent Decisions and Developments
Strategic Considerations for U.S. Applicants and Patentees
Welcome to BARBRI, the trusted global leader in legal education. Continue to access the same expert-led Strafford CLE and CPE webinars you know and value. Plus, explore professional skills courses and more.
About the Course
Introduction
This CLE course will guide patent counsel on the EU Unitary Patent System (UPS) and the Unified Patent Court (UPC). The panel will also discuss recent decisions, developments, and strategic considerations for U.S. applicants and patentees with European portfolios.
Description
The UPS and UPC opened for business in 2023, affecting existing and future European patents and applications.
Applicants now have the option to make use of the Unitary Patent System (UPS) to cover many EU countries in one patent right. This potentially offers a significant reduction in costs over the “classical” European grant procedure, depending on in which EU states you pursue protection and for how long.
Many European patents are now being litigated centrally at the new Unified Patent Court (UPC). The UPC allows coordination of strategy and procedures and provides broader enforcement across most of the EU in a single action. However, the potential significant reduction in costs could be offset by the substantial risk of a single central revocation action also with effect across the same territories.
Over the past year there have been significant decisions from the UPC focusing on patentability and infringement as well as jurisdiction and the long arm of the UPC. Two Local Divisions found jurisdiction over infringement claims of foreign patents even if the country is not participating in the UPC (BSH v. Electrolux and Hurom v. NEC). The UPC Court of Appeal has also provided insight on assessment of inventive step (Amgen v Sanofi and Meril v Edwards).
Listen as our authoritative panel examines recent decisions and developments relating to the UPS and UPC and what this means for patent applications and enforcement. The panel will also discuss strategic considerations for U.S. applicants and patentees.
Presented By
Dr. Ford is a European and UK patent attorney with extensive experience drafting patent applications and prosecuting them globally. She has particular experience of patent prosecution at the European Patent Office (EPO) in the fields of biotechnology (including antibodies, vaccines, genes and proteins), and pharmaceuticals (including drug formulation, diagnostics and new administration regimes). Alongside Dr. Ford’s substantial experience with EPO opposition and appeal proceedings, she also advises clients on all aspects of patent strategy, including coordination of related patents and patent applications worldwide, and interactions between drafting, prosecution and opposition matters.
Mr. Wall is a European and UK patent attorney and litigator specializing in the chemical, consumer products, energy, material, mechanical, medical and pharmaceutical sectors. Prior to founding Oxon IP, he was a Partner in major European and US Intellectual Property law firms, and before then in-house patent counsel for some of the world’s largest US and European multinationals. Mr. Wall regularly represents clients in Opposition and Appeal proceedings before the European Patent Office (EPO) as lead counsel in a wide variety of technical areas. He has won numerous defensive and offensive oppositions, including multi-party proceedings, and successful coordination with disputes in multiple jurisdictions such as UK, Germany, US, China, Japan, Korea, and India. Mr. Wall is a frequent author and lecturer on patent law, he has had numerous articles published in legal journals and spoken at international programs and conferences in Europe, USA and Asia, as well as before Fortune 500 companies. Mr. Wall is listed as a Patent Star by MIP, a WIPR Leader and appears on the IAM 1000 (The World’s Leading Patent Professionals), the IAM 300 (The World’s Leading IP Strategists and Global Leaders) and the Legal 500, specifically cited for his EPO Opposition experience.
-
This 90-minute webinar is eligible in most states for 1.5 CLE credits.
-
Live Online
On Demand
Date + Time
- event
Tuesday, April 7, 2026
- schedule
1:00 PM ET/10:00 AM PT
I. Review of the UPS and UPC
II. Recent decisions and their impact
III. Strategic considerations for U.S. applicants and patentees with European portfolios
IV. Guidance on what needs to be done
The panel will review these and other important issues:
- What are the advantages and disadvantages of the UPS? What are the benefits and risks of the UPC?
- What key considerations should companies and their counsel keep in mind as they navigate the UPS and UPC systems?
- What steps should patent counsel consider as the UPS and UPC evolve?
Unlimited access to premium CLE courses:
- Annual access
- Available live and on-demand
- Best for attorneys and legal professionals
Unlimited access to premium CPE courses.:
- Annual access
- Available live and on-demand
- Best for CPAs and tax professionals
Unlimited access to premium CLE, CPE, Professional Skills and Practice-Ready courses.:
- Annual access
- Available live and on-demand
- Best for legal, accounting, and tax professionals
Unlimited access to Professional Skills and Practice-Ready courses:
- Annual access
- Available on-demand
- Best for new attorneys
Related Courses
EU Unitary Patent System and UPC: Recent Decisions and Developments
Tuesday, April 7, 2026
1:00 PM ET/10:00 AM PT
Pleading Requirements for Patent Infringement Amid Inconsistent Court Treatment
Available On-Demand